vTv Therapeutics Inc.
VTVT
$22.23
-$0.27-1.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.00K | -- | -- | 1.00M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.00K | -- | -- | 1.00M | -- |
| Cost of Revenue | -7.08M | 3.22M | 217.00K | 2.65M | 2.14M |
| Gross Profit | 7.11M | -3.22M | -217.00K | -1.65M | -2.14M |
| SG&A Expenses | 2.68M | 3.28M | 3.72M | 3.98M | 2.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.91M | 6.51M | 7.16M | 6.63M | 4.71M |
| Operating Income | -4.89M | -6.51M | -7.16M | -5.63M | -4.71M |
| Income Before Tax | -4.44M | -5.84M | -6.41M | -5.92M | -4.44M |
| Income Tax Expenses | 0.00 | -- | -- | 100.00K | -- |
| Earnings from Continuing Operations | -4.44M | -5.84M | -6.41M | -6.02M | -4.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 803.00K | 1.06M | 1.23M | 1.15M | 963.00K |
| Net Income | -3.63M | -4.78M | -5.18M | -4.87M | -3.48M |
| EBIT | -4.89M | -6.51M | -7.16M | -5.63M | -4.71M |
| EBITDA | -4.87M | -6.48M | -7.13M | -5.61M | -4.68M |
| EPS Basic | -0.55 | -0.88 | -0.81 | -2.00 | -1.67 |
| Normalized Basic EPS | -0.30 | -0.48 | -0.43 | -1.05 | -0.87 |
| EPS Diluted | -0.55 | -0.88 | -0.81 | -2.00 | -1.67 |
| Normalized Diluted EPS | -0.30 | -0.48 | -0.43 | -1.05 | -0.87 |
| Average Basic Shares Outstanding | 6.58M | 5.46M | 6.40M | 2.43M | 2.09M |
| Average Diluted Shares Outstanding | 6.58M | 5.46M | 6.40M | 2.43M | 2.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |